Abstract. Previous studies have demonstrated that several members of the Forkhead-box (FOX) family of genes are associated with tumor progression and metastasis. The objective of the current study was to screen candidate FOX family genes identified from analysis of molecular networks in clear cell renal cell carcinoma (ccRCC). The expression of FOX family genes as well as FOX family-associated genes was examined, and Kaplan-Meier survival analysis was performed in The Cancer Genome Atlas (TCGA) cohort (n=525). Patient characteristics, including sex, age, tumor diameter, laterality, tumor-node-metastasis, tumor grade, stage, white blood cell count, platelet count, the levels of hemoglobin, overall survival (OS) and disease-free survival (DFS), were collected for univariate and multivariate Cox proportional hazards ratio analyses. A total of seven candidate FOX family genes were selected from the TCGA database subsequent to univariate and multivariate Cox proportional hazards ratio analyses.
Introduction
Renal cell carcinoma (RCC), which accounts for 2-3% of all adult malignancies, is a relatively common malignancy with an incidence rate that is increasing at a rate of 2% each year (1) . Clear cell renal cell carcinoma (ccRCC), which accounts for ~90% of RCC cases (2) , is the most common histological subtype of RCC and exhibits a 5-year disease-specific survival rate of 50-69% (3). RCC is notoriously refractory to radiation therapy and standard chemotherapy. If detected at an early stage, ccRCC can be cured by surgery. However, ~25% of patients with RCC are identified with lymph node metastasis or distant metastasis at first diagnosis, and 30-40% of patients experience recurrence or metastasis even following surgery (4) . Currently, the primary prognostic index for ccRCC is the Fuhrman nuclear grade and disease staging at the time of surgery (5) . Thus, it is important to develop new biomarkers to screen out high-risk patients for additional appropriate postoperative therapy and surveillance.
Forkhead-box (FOX) family proteins are involved in the regulation of cell growth and differentiation as well as embryogenesis and tissue development. These proteins are characterized by a conserved FOX domain and extra-FOX protein-protein interaction domains (6) . The FOX domain is ~100 amino acids in length and is involved in DNA binding (6) (7) (8) . The extra-FOX regions are involved in interactions with transcriptional activators, transcriptional repressors or DNA repair complexes (6, 7) . Previous studies have demonstrated an association between the expression of FOX family genes and the prognosis of different types of cancer, including lung cancer, basal cell carcinoma, esophageal cancer, pancreatic cancer, rhabdomyosarcoma, acute myeloblastic leukemia and acute lymphocytic leukemia (9) . However, the role of FOX family genes in ccRCC has not been described.
The present study examined the expression of FOX family genes in 525 ccRCC cases from The Cancer
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Genome Atlas (TCGA) database with the aim of potentially identifying a prognostic marker for ccRCC. The associations between FOX family-related gene expression and clinicopathological characteristics were also investigated.
Materials and methods
Patients and data. The expression levels of FOX family genes, FOX family-related genes, and associated clinical data were downloaded from the TCGA data portal, which is available from the Cancer Genomics Browser of the University of California Santa Cruz (https://genome-cancer.ucsc.edu/). A total of 51 gene members of the FOX family were studied in 525 primary ccRCC tumors from patients with detailed FOX family gene expression data, and related clinical follow-up data was selected from the updated TCGA data portal. Patients included a total of 184 females and 341 males (age range, 26-90 years; median age, 61 years). All patients had received partial or radical nephrectomy. The enrolled patients had not received pretreatment and had fully characterized tumors, complete RNA sequencing information and intact overall survival (OS) and disease-free survival (DFS) information. Appropriate genes were selected to construct gene networks according to the standards described in a previous study (10 Table II) .
Kaplan-Meier analysis was performed with the cut-off set at the median expression level of each FOX family gene. The Table II . Continued. Tumors on the left kidney set as 0 and tumors on the right kidney set as 1. CI, confidence interval; HR, hazards ratio; FOX, forkhead-box; Hb, preoperative hemoglobin count; WBC, preoperative white blood cell count; PLT, preoperative platelet count; TNM, tumor-node-metastasis. Fig. 3 , and details of the genes in the network are shown in Table VI. The data from univariate Cox proportional hazards ratio analysis indicated that the expression levels of acyl-coenzyme A dehydrogenase, C-4 to C-12 straight chain, androgen receptor, α-fetoprotein, bone morphogenetic protein receptor type II, CCAAT/enhancer-binding protein β, engrailed homeobox 2, hydroxyacyl-coenzyme A dehydrogenase, 3-hydroxy-3-methylglutaryl-coenzyme A synthase 1, hepatocyte nuclear factor 4α, insulin-like growth factor binding protein 1, interleukin-2 (IL-2), potassium inwardly-rectifying channel subfamily J member 11, NCOA1, NCOA3, NDUFV3, PISD, PKLR and uncoupling protein 2 were associated with OS. Multivariate analysis for prognostic factors was performed by the Cox proportional hazards ratio analysis and revealed that the expression of NCOA1, NDUFV3, PISD and PKLR were independent prognostic factors for OS in the TCGA cohort (Table VII) .
Discussion
In the present study, it was revealed that FOXA1, FOXA2, FOXD1, FOXD4L2, FOXK2 and FOXL1 genes were risk factors for clinical outcome of ccRCC. However, high expression of the FOXN2 gene was associated with longer survival in the TCGA cohort. Furthermore, in a network of FOX family-related genes, NCOA1, NDUFV3, PISD and PKLR were identified as independent prognostic factors for OS in patients with ccRCC.
FOXA1 and FOXA2 are two members of the FOXA transcription factor family. FOXA1, also termed HNF-3, has an important role in the progression of bladder, prostate and breast cancer (12) (13) (14) (15) . A previous study has demonstrated that downregulation of FOXA1 is associated with poor OS in human bladder cancer (12) . FOXA1 may also be a potential treatment target of breast and prostate cancer due to its effects on chromatin remodeling via androgen and estrogen receptors (16) . FOXA2 is involved in proliferation, differentiation and maintenance of cancer stem cells (17) (18) (19) . However, FOXA2 may have different roles in different tissues. FOXA2 is associated with the prognosis of human gastric cancer, and patients with high FOXA2 expression level had longer OS compared with patients with low FOXA2 expression (19) . However, one study conducted in breast carcinoma revealed that FOXA2 promotes the development of triple-negative/basal-like tumors (18) .
FOXD1 performs an essential role in numerous biological processes, including proliferation, differentiation and tumorigenesis (20, 21) . Upregulation of FOXD1 is associated with the development of resistance to chemotherapy in patients with prostate and ovarian cancer (22) . Another study reported that FOXD1 is upregulated in breast cancer, and the depletion or overexpression of FOXD1 may cause changes in proliferation and chemoresistance (20) . FOXK2, also termed ILF or ILF1, was first identified as a regulator of IL-2 transcription. FOXK2 upregulates activator protein-1 (AP-1)-dependent gene expression through its interaction with AP-1 and accelerates the binding of AP-1 to chromatin (23) . FOXL1 is associated with pancreatic carcinoma and has an important inhibitory role in pancreatic tumor progression (24) . However, to the best of our knowledge, no study has examined FOXD4L2 to date, and the findings of the present study suggest that FOXD4L2 should be investigated further in future studies. In addition, it was observed in the present study that high FOXN2 mRNA expression was associated with longer OS, and this is consistent with previous results in glioblastoma multiforme (25) . Previous studies have shown that FOX genes have an essential role in the progression of several types of tumors, including ccRCC (9, (12) (13) (14) 19, 21) . However, to the best of our knowledge, the present study is the first to comprehensively examine the association between the outcome of ccRCC and the gene expression of the entire FOX gene family. The detailed mechanisms remain unknown and would need to be investigated in future studies.
The present study also investigated the association between FOX-related genes and prognosis of patients with ccRCC. The results indicated that the FOX-associated genes NCOA1, NDUFV3, PISD and PKLR are associated with OS of patients with ccRCC. It has been previously demonstrated that the nuclear co-activator NCOA1 (SRC-1) is able to promote breast cancer metastasis through directly targeting macrophage colony-stimulating factor 1 expression (26) . Overexpression of NCOA1 is associated with resistance to endocrine therapy and disease recurrence (26) . The NDUFV3 gene is located at chromosome 21q22.3 and may be associated with the occurrence of Down syndrome (27) . Although limited information is known about PISD, one study reported that PISD was associated with tumorigenesis and tumor growth (28) . The PKLR gene is considered to be involved in pyruvate kinase-deficient hemolytic anemia (29) .
The major strength of the present study is that it is the first comprehensive evaluation of the association between FOX genes and the prognosis of patients with ccRCC. The study involved a large cohort, and the clinical follow-up was long. These findings will help provide the foundation to elucidate the mechanisms of FOX genes and their function in ccRCC.
However, the present study also has a number of limitations. Firstly, only data from TCGA database was analyzed and further validation is required. Secondly, the present study did not investigate the specific mechanisms of action of FOX genes in patients with ccRCC. Additionally, the FOX gene signature may not be sufficient to predict the prognosis of ccRCC, since other factors (tumor stage, surgical procedures, state of nutrition, economic issues, response to sunitinib, comorbidities and lifestyle factors), can also affect the prognosis of ccRCC (5, 9, 11, 30) . Therefore, additional study is required to examine the association between FOX genes and ccRCC.
----------------------------------------------------------------------------------------------------------------------------------------------------
Findings of the present study suggest that the expression of FOX family genes FOXA1, FOXA2, FOXD1, FOXD4L2, FOXK2, FOXL1 and FOXN2 and FOX family-related genes NCOA1, NDUFV3, PISD and PKLR are associated with survival in patients with ccRCC. Findings of the present study and the specific underlying require further investigation.
